Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial | Zendy

Martin Tauschmann | Zendy; Janet M. Allen | Zendy; Malgorzata E. Wilinska | Zendy; Hood Thabit | Zendy; Carlo L. Acerini | Zendy; David B. Dunger | Zendy; Roman Hovorka | Zendy

Open Access

Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial

Author(s) -

Martin Tauschmann,

Janet M. Allen,

Malgorzata E. Wilinska,

Hood Thabit,

Carlo L. Acerini,

David B. Dunger,

Roman Hovorka

Publication year - 2016

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc16-1094

Subject(s) - medicine , interquartile range , insulin , type 1 diabetes , crossover study , insulin pump , diabetes mellitus , randomized controlled trial , bolus (digestion) , artificial pancreas , type 2 diabetes , endocrinology , alternative medicine , pathology , placebo

This study evaluated the feasibility, safety, and efficacy of day-and-night hybrid closed-loop insulin delivery in adolescents with type 1 diabetes under free-living conditions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research